NDC 11004-502 - Dressol-X Radiopaque D-502
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11004-502
- Package NDCs from labels
- 11004-502-40
- Manufacturer
- Rainbow Specialty & Health Products, Inc.
- Effective date
- 2011-12-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dressol-X Radiopaque D-502 - Rainbow Specialty & Health Products, Inc. | Rainbow Specialty & Health Products, Inc. | 2011-12-13 | MEDICAL DEVICE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11004-502-40 | Dressol-XRadiopaque D-502 | 1 in 1 BOTTLE | DRESSING | 1 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | DRESSOL-X RADIOPAQUE D-502 (ASPIRIN ) DRESSING [RAINBOW SPECIALTY & HEALTH PRODUCTS, INC.] | 5 | |
| EUGENOL | ACTIVE INGREDIENT | 3T8H1794QW | DRESSOL-X RADIOPAQUE D-502 (ASPIRIN ) DRESSING [RAINBOW SPECIALTY & HEALTH PRODUCTS, INC.] | 5 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | DRESSOL-X RADIOPAQUE D-502 (ASPIRIN ) DRESSING [RAINBOW SPECIALTY & HEALTH PRODUCTS, INC.] | 5 | |
| EUGENOL | ACTIVE MOIETY | 3T8H1794QW | DRESSOL-X RADIOPAQUE D-502 (ASPIRIN ) DRESSING [RAINBOW SPECIALTY & HEALTH PRODUCTS, INC.] | 5 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | DRESSOL-X RADIOPAQUE D-502 (ASPIRIN ) DRESSING [RAINBOW SPECIALTY & HEALTH PRODUCTS, INC.] | 5 | |
| PARAFFIN | INACTIVE INGREDIENT | I9O0E3H2ZE | DRESSOL-X RADIOPAQUE D-502 (ASPIRIN ) DRESSING [RAINBOW SPECIALTY & HEALTH PRODUCTS, INC.] | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Haleon US Holdings LLC | a71074a6-cc19-4bb3-8c84-4e82a8906801 | 2024-04-22 | Warnings | R16CO5Y76E |
| Regular Strength Aspirin 325 mg | ASPIRIN | Kroger | 0fc3193d-af4e-ff3a-e063-6294a90a2743 | 2024-04-17 | Warnings | R16CO5Y76E |
| aspirin low dose chewable | ASPIRIN | Time-Cap Labs, Inc | 5d56618c-8ea2-42ea-a9f2-339bd0055ddd | 2024-04-17 | Warnings | R16CO5Y76E |
| Low Dose Aspirin | ASPIRIN | P & L Development, LLC | 0058175f-3474-40c3-a046-6cfaec86d84b | 2024-04-16 | Warnings | R16CO5Y76E |
| Handy Solutions Headache Pain Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Navajo Manufacturing Company Inc. | e5481abe-6971-2bc5-e053-2995a90ae895 | 2024-04-15 | Warnings | R16CO5Y76E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | H E B | 4d572228-3141-4539-9c3d-2fd06e94eee3 | 2024-04-09 | Warnings | R16CO5Y76E |
| Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Haleon US Holdings LLC | 1b5ff867-5442-4cf8-bd1e-530093cc88f8 | 2024-04-05 | Warnings | R16CO5Y76E |
| Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Haleon US Holdings LLC | 0faa3592-4d56-4645-9a0e-066e0bdfebb6 | 2024-04-05 | Warnings | R16CO5Y76E |
| Low Dose Aspirin | ASPIRIN | H E B | edb321dd-e5cb-4031-a8a8-efce9e86fe16 | 2024-04-03 | Warnings | R16CO5Y76E |
| Regular Strength Enteric coated aspirin | ASPIRIN | Bryant Ranch Prepack | bda805ab-7f37-405d-a144-4e06ad9a29a1 | 2024-04-03 | Warnings | R16CO5Y76E |
| FLEET | MINERAL OIL | C.B. Fleet Company, Inc. | e0b7acab-add4-4daf-b1df-bb7cf5ca8e19 | 2024-04-01 | Warnings | T5L8T28FGP |
| Signature Care Migraine Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Safeway | 66695667-97a3-4329-8ce0-0fffa8628951 | 2024-03-27 | Warnings | R16CO5Y76E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Family Dollar (FAMILY WELLNESS) | 650cb15e-c448-4df3-b0f8-4398be05d841 | 2024-03-27 | Warnings | R16CO5Y76E |
| Good Sense Effervescent Pain Relief | ASPIRIN | Perrigo Direct, Inc. | 103027a7-2f0e-8d8c-e063-6294a90aedc7 | 2024-03-26 | Warnings | R16CO5Y76E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 5ffcc78d-9163-4cb4-8811-ae9f0142806a | 2024-03-18 | Warnings | R16CO5Y76E |
| ASPIRIN LOW DOSE CHEWABLE ORANGE PAIN RELIEVER | ASPIRIN LOW DOSE CHEWABLE ORANGE PAIN RELIEVER | HF Acquisition Co LLC, DBA HealthFirst | 13e621dc-b2b4-98fd-e063-6394a90acc75 | 2024-03-17 | Warnings | R16CO5Y76E |
| Excedrin PM Triple Action Caplets | ACETAMINOPHEN, ASPIRIN (NSAID) AND DIPHENHYDRAMINE CITRATE | Haleon US Holdings LLC | b3812d27-40af-40d7-864a-dfa4ae34cb9e | 2024-03-14 | Warnings | R16CO5Y76E |
| Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Haleon US Holdings LLC | 691b754c-bafc-47e2-a322-cf56245c01f6 | 2024-03-14 | Warnings | R16CO5Y76E |
| Bio Cytotox Phase | PODOPHYLLUM PELTATUM, ASCORBICUM ACIDUM, GALIUM APARINE, HYDRASTIS CANADENSIS, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SARCOLACTICUM ACIDUM, THIAMINUM HYDROCHLORICUM, ALPHA-LIPOICUM ACIDUM, COLCHICUM AUTUMNALE, CONIUM MACULATUM, NATRUM OXALACETICUM, SULPHUR, VACCINIUM MYRTILLUS, NOREPINEPHRINE, ACETYLSALICYLICUM ACIDUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ANTHRACHINONUM, HISTAMINUM HYDROCHLORICUM, MAGNESIUM GLUCONICUM DIHYDRICUM, NADIDUM, NAPHTHOCHINONUM, PANTOTHENIC ACID, UBIDECARENONUM, | Deseret Biologicals, Inc. | ca632470-6cbc-4994-a7f0-95b6ad9aa44f | 2024-03-14 | Warnings | R16CO5Y76E |
| EXCEDRIN MIGRAINE | ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE | Haleon US Holdings LLC | 920c8898-e222-4b91-afc5-04d25317ade7 | 2024-03-14 | Warnings | R16CO5Y76E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.